Precision BioSciences Announces $125 Million Public Offering of Common Shares and Warrants
Precision BioSciences (DTIL) has announced a public offering consisting of 10.24 million common shares priced at $7.75 per share. The deal is supplemented by pre-funded warrants allowing for the purchase of up to 5.89 million additional shares at approximately $7.75 per warrant. The company expects to generate roughly $125 million in gross proceeds from this underwritten offering. This capital infusion provides the biotechnology firm with significant liquidity to support its ongoing operations and development programs.
Tickers: $DTIL
Topics: capital raising common shares warrants
Read the full article at Seeking Alpha
Part of the story Ingram Micro Announces Secondary Offering of 11 Million Common Shares (3 articles)